Latest Tri Locum Partners LP Stock Portfolio
Tri Locum Partners LP Performance:
2024 Q3: 7.9%YTD: 35.59%2023: 17.97%
Performance for 2024 Q3 is 7.9%, and YTD is 35.59%, and 2023 is 17.97%.
About Tri Locum Partners LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Tri Locum Partners LP reported an equity portfolio of $417.4 Millions as of 30 Sep, 2024.
The top stock holdings of Tri Locum Partners LP are PFE, TEVA, NTRA. The fund has invested 12% of it's portfolio in PFIZER INC and 11.9% of portfolio in TEVA PHARMACEUTICAL INDS LTD.
The fund managers got completely rid off ASCENDIS PHARMA A/S, AMGEN INC (AMGN) and REGENERON PHARMACEUTICALS (REGN) stocks. They significantly reduced their stock positions in AXSOME THERAPEUTICS INC (AXSM), INSMED INC (INSM) and MERUS N V (MRUS). Tri Locum Partners LP opened new stock positions in AVADEL PHARMACEUTICALS PLC and VERONA PHARMA PLC (VRNA). The fund showed a lot of confidence in some stocks as they added substantially to MIND MEDICINE MINDMED INC (MNMD), STEVANATO GROUP S P A and PFIZER INC (PFE).
The top stock holdings of Tri Locum Partners LP are PFE, TEVA, NTRA. The fund has invested 12% of it's portfolio in PFIZER INC and 11.9% of portfolio in TEVA PHARMACEUTICAL INDS LTD.
The fund managers got completely rid off ASCENDIS PHARMA A/S, AMGEN INC (AMGN) and REGENERON PHARMACEUTICALS (REGN) stocks. They significantly reduced their stock positions in AXSOME THERAPEUTICS INC (AXSM), INSMED INC (INSM) and MERUS N V (MRUS). Tri Locum Partners LP opened new stock positions in AVADEL PHARMACEUTICALS PLC and VERONA PHARMA PLC (VRNA). The fund showed a lot of confidence in some stocks as they added substantially to MIND MEDICINE MINDMED INC (MNMD), STEVANATO GROUP S P A and PFIZER INC (PFE).
Tri Locum Partners LP Annual Return Estimates Vs S&P 500
Our best estimate is that Tri Locum Partners LP made a return of 7.9% in the last quarter. In trailing 12 months, it's portfolio return was 52.94%.
New Buys
| Ticker | $ Bought |
|---|---|
| avadel pharmaceuticals plc | 21,783,400 |
| verona pharma plc | 17,088,800 |
| biohaven ltd | 9,653,950 |
New stocks bought by Tri Locum Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| mind medicine mindmed inc | 335 |
| stevanato group s p a | 230 |
| pfizer inc | 190 |
| vaxcyte inc | 139 |
| natera inc | 37.67 |
| inspire med sys inc | 13.62 |
| united therapeutics corp del | 9.63 |
| teva pharmaceutical inds ltd | 8.06 |
Additions to existing portfolio by Tri Locum Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| axsome therapeutics inc | -70.08 |
| insmed inc | -54.53 |
| merus n v | -42.73 |
| madrigal pharmaceuticals inc | -33.76 |
| argenx se | -16.21 |
| korro bio inc | -10.38 |
Tri Locum Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| avadel pharmaceuticals plc | -16,724,600 |
| ocular therapeutix inc | -3,520,150 |
| ascendis pharma a/s | -31,062,200 |
| xenon pharmaceuticals inc | -3,975,380 |
| amgen inc | -25,705,600 |
| praxis precision medicines i | -3,115,190 |
| alnylam pharmaceuticals inc | -10,935,000 |
| regeneron pharmaceuticals | -18,409,800 |
Tri Locum Partners LP got rid off the above stocks
Sector Distribution
Tri Locum Partners LP has about 68.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 68.7 |
| Others | 31.3 |
Market Cap. Distribution
Tri Locum Partners LP has about 40.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 40.8 |
| UNALLOCATED | 31.3 |
| MID-CAP | 25.7 |
| SMALL-CAP | 2.3 |
Stocks belong to which Index?
About 26.1% of the stocks held by Tri Locum Partners LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 73.8 |
| RUSSELL 2000 | 14.1 |
| S&P 500 | 12 |
Tri Locum Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Tri Locum Partners LP
Tri Locum Partners LP has 20 stocks in it's portfolio. About 79.9% of the portfolio is in top 10 stocks. MDGL proved to be the most loss making stock for the portfolio. INSP was the most profitable stock for Tri Locum Partners LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALNY | alnylam pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMGN | amgen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVDL | avadel pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 1.98 | 91,721 | 8,242,970 | reduced | -70.08 | ||
| FEMY | femasys inc | 0.01 | 30,606 | 33,973 | unchanged | 0.00 | ||
| INSM | insmed inc | 2.52 | 143,920 | 10,506,200 | reduced | -54.53 | ||
| INSP | inspire med sys inc | 7.66 | 151,429 | 31,959,100 | added | 13.62 | ||
| MDGL | madrigal pharmaceuticals inc | 2.20 | 43,287 | 9,186,370 | reduced | -33.76 | ||
| MNMD | mind medicine mindmed inc | 2.27 | 1,662,950 | 9,462,200 | added | 335 | ||
| MRUS | merus n v | 2.30 | 192,157 | 9,600,160 | reduced | -42.73 | ||
| NTRA | natera inc | 9.65 | 317,439 | 40,298,900 | added | 37.67 | ||
| OCUL | ocular therapeutix inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PCVX | vaxcyte inc | 7.44 | 271,922 | 31,072,500 | added | 139 | ||
| PFE | pfizer inc | 12.02 | 1,732,940 | 50,151,100 | added | 190 | ||
| PRAX | praxis precision medicines i | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| REGN | regeneron pharmaceuticals | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| TEVA | teva pharmaceutical inds ltd | 11.90 | 2,755,740 | 49,658,400 | added | 8.06 | ||
| UTHR | united therapeutics corp del | 4.72 | 54,926 | 19,682,700 | added | 9.63 | ||
| VRNA | verona pharma plc | 4.09 | 593,980 | 17,088,800 | new | |||
| XENE | xenon pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||